(Q36223781)

12 August 2017

1 reference

title

Hepatitis C virus infection in HIV-infected patients (English)

1 reference

12 August 2017

1 reference

1

Mark S Sulkowski

1 reference

12 August 2017

1 September 2004

1 reference

12 August 2017

Current HIV/AIDS reports

1 reference

12 August 2017

1

1 reference

12 August 2017

3

1 reference

12 August 2017

128-135

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-004-0019-6

12 August 2017

0 references

cites work

Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

1 reference

https://api.crossref.org/works/10.1007%2FS11904-004-0019-6

Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-004-0019-6

Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-004-0019-6

Hepatitis C in the HIV-Infected Person

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-004-0019-6

Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-004-0019-6

Liver biopsy findings in 501 patients infected with human immunodeficiency virus (HIV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-004-0019-6

A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-004-0019-6

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-004-0019-6

Survival of Human Immunodeficiency Virus–Infected Liver Transplant Recipients

21 January 2018

1 reference

12 December 2020

Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects

1 reference

12 December 2020

Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro

1 reference

12 December 2020

Determinants of the quantity of hepatitis C virus RNA.

1 reference

12 December 2020

Safety and Immunogenicity of Hepatitis A Vaccine in Human Immunodeficiency Virus–Infected Patients: A Double‐Blind, Randomized, Placebo‐Controlled Trial

1 reference

12 December 2020

Diagnosis, management, and treatment of hepatitis C

1 reference

12 December 2020

Antiviral action of ribavirin in chronic hepatitis C.

1 reference

12 December 2020

Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population

1 reference

12 December 2020

Hepatitis C and progression of HIV disease

1 reference

12 December 2020

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Hepatitis C virus infection in sexually active homosexual men.

1 reference

12 December 2020

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

12 December 2020

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group

1 reference

12 December 2020

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

1 reference

12 December 2020

1 reference

12 December 2020

Hospitalization Rates Differ by Hepatitis C Status in an Urban HIV Cohort

1 reference

12 December 2020

Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).

1 reference

12 December 2020

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

1 reference

12 December 2020

1 reference

12 December 2020

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

1 reference

12 December 2020

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

1 reference

12 December 2020

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

1 reference

12 December 2020

End-stage liver disease in persons with hemophilia and transfusion-associated infections.

1 reference

12 December 2020

Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study

1 reference

12 December 2020

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

1 reference

12 December 2020

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

12 December 2020

Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Risk factors for hepatitis C virus seropositivity in heterosexual couples

1 reference

12 December 2020

Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection

1 reference

12 December 2020

Antibody to Hepatitis C Virus among Cardiac Surgery Patients, Homosexual Men, and Intravenous Drug Users in Baltimore, Maryland

1 reference

12 December 2020

Ribavirin antagonizes the effect of azidothymidine on HIV replication

1 reference

12 December 2020

Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention

1 reference

12 December 2020

The role of liver biopsy in hepatitis C.

1 reference

12 December 2020

Screening for hepatitis C virus in human immunodeficiency virus-infected individuals

1 reference

12 December 2020

Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus

1 reference

12 December 2020

Serum assays for liver fibrosis.

1 reference

12 December 2020

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

1 reference

12 December 2020

Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study.

1 reference

12 December 2020

10.1007/S11904-004-0019-6

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16091233